Legal Representation
Attorney
Thomas J. Donovan
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 16, 2018 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 15, 2018 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 4, 2017 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 4, 2017 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 4, 2017 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Dec 4, 2017 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 17, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 15, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 15, 2017 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jun 15, 2017 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 17, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 15, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 15, 2016 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Dec 15, 2016 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 22, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 21, 2016 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 20, 2016 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 14, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 14, 2016 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 15, 2015 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 20, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 20, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 30, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 14, 2015 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Sep 8, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 11, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 10, 2015 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 10, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 22, 2015 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 22, 2015 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| May 22, 2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 8, 2015 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| May 5, 2015 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Apr 17, 2015 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Apr 15, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 31, 2015 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Mar 31, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 31, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 3, 2015 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Feb 3, 2015 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Feb 3, 2015 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Dec 30, 2014 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 30, 2014 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 30, 2014 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 17, 2014 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 9, 2014 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 9, 2014 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 9, 2014 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 9, 2014 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 29, 2014 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 009
Electronic publications, namely, reports, books and newsletters in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning recorded on computer media; digital media and recordings, namely, pre-recorded DVDs, downloadable audio and video recordings, and CDs in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; electronic books in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning recorded on computer media; downloadable electronic publications in the nature of reports, books and newsletters in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; downloadable digital media and recordings namely, electronic video recordings in the fields of biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; Downloadable electronic data files featuring data in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; computer software for desktop publishing
First Use Anywhere:
0
First Use in Commerce:
0
Class 035
Advertising services; business management; business administration services and managing office functions in the nature database management for others; business information management services; business consultancy services; business management and organisation consultancy services; provision of business and commercial information for the academic and scientific, and professional and business communities in the fields of biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; business research services; commercial information agency services; provision of statistical information for business and commercial purposes in the field of business investments, mergers and acquisitions; conducting public opinion polling services; conducting market opinion polling studies; compilation and systemisation of information into computer databases; computerised file managing; document reproduction; arranging newspapers and magazine subscriptions for others; news clipping services; publication of publicity texts; marketing research and marketing research studies; arranging and conducting exhibitions, conferences, congresses, conventions and trade shows for business and commercial purposes; data retrieval services, namely, providing an on-line searchable database featuring business information and commercial information; business information and advisory services; research and analysis in the fields of economics; providing business information and business news relating to business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs industry, biotechnology medical products industry, biotherapeutics industry, and biologicals and related research and development industries; preparing financial reports for others; preparing financial reports for others via the Internet, telecommunication and other electronic communication networks; providing information and news in the fields of mergers and acquisitions of corporations
First Use Anywhere:
0
First Use in Commerce:
0
Class 036
Financial advice and consultancy services; financial research, analysis, forecasting and advisory services; financial information; financial information relating to mergers, acquisitions, corporate transactions, debt finance, debt trading and debt issuance; debt collection services; financial information evaluation, appraisal, forecasting and reporting; financial analysis; financial research services; financial information and financial advisory services; financial advice and consultancy services provided online via the Internet, telecommunication and other electronic communication networks; financial research, analysis, forecasting and advisory services provided online via the Internet, telecommunication and other electronic communication networks; financial information provided online via the Internet, telecommunication and other electronic communication networks; financial information relating to mergers, acquisitions, corporate transactions, debt finance, debt trading and debt issuance provided online via the Internet, telecommunication and other electronic communication networks; debt collection services provided online via the Internet, telecommunication and other electronic communication networks; financial information evaluation, appraisal, forecasting and reporting provided online via the Internet, telecommunication and other electronic communication networks; financial analysis provided online via the Internet, telecommunication and other electronic communication networks; financial research services provided online via the Internet, telecommunication and other electronic communication networks; financial information and financial advisory services provided online via the Internet, telecommunication and other electronic communication networks; providing information and news in the fields of corporate financial transactions, debt finance, debt trading, debt issuance, investment advice on biotechnology drugs, investment advice on biotechnology medical products, investment advice on biotherapeutics and investment advice on biologicals and related research and development companies, investment strategies for high net worth individuals, and financial retirement planning; providing financial information and financial news relating to business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs industry, biotechnology medical products industry, biotherapeutics industry, and biologicals and related research and development industries, investment strategies for high net worth individuals, and retirement planning
First Use Anywhere:
0
First Use in Commerce:
0
Class 041
Education services, namely, providing of training in the fields of business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; arranging and conducting seminars in the fields of business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; library services provided by means of a computer database which feature on-line newspapers, magazines, photographs and pictures via an on-line computer network; publication of reports, books and newsletters in the field of financial information, financial reports and financial analysis
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Providing scientific information and related research and development information in the fields of biotechnology drugs, biotechnology medical products, biotherapeutics, and biologicals
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of a design of four squares with two squares on top and two on the bottom linked by four lines and placed to the left of the mark "BioPharm Insight".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
009
035
036
041
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOPHARM"